Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
Authors
Keywords
Cancer biomarker, Epithelial-mesenchymal transition, Tumor spheroids, Ovarian carcinoma, Metastasis, Ascites
Journal
TUMOR BIOLOGY
Volume 36, Issue 9, Pages 7213-7219
Publisher
Springer Nature
Online
2015-04-18
DOI
10.1007/s13277-015-3437-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P3.04 * Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer
- (2015) S. Masoumi-Moghaddam et al. ANNALS OF ONCOLOGY
- Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy
- (2015) Chiara Della Pepa et al. CANCER TREATMENT REVIEWS
- Environmental (nongenetic) factors in gynecological cancers: update and future perspectives
- (2015) Penelope M Webb Future Oncology
- Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis
- (2015) Patrice Desmeules et al. HUMAN PATHOLOGY
- The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
- (2015) Ben Davidson et al. HUMAN PATHOLOGY
- Lymphatic Mapping and Ligation for Persistent Ascites After Surgery for Gynecologic Malignancy
- (2015) Jo Marie Tran Janco et al. OBSTETRICS AND GYNECOLOGY
- Risks associated with premature ovarian failure in Han Chinese women
- (2015) Huidan Wang et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Differential Roles of uPAR in Peritoneal Ovarian Carcinomatosis
- (2015) Nada N. Al-Hassan et al. NEOPLASIA
- Semiquantitative GATA-3 Immunoreactivity in Breast, Bladder, Gynecologic Tract, and Other Cytokeratin 7–Positive Carcinomas
- (2014) Beth Z. Clark et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
- (2014) I Brana et al. BRITISH JOURNAL OF CANCER
- Akt2 Mediates TGF-�1-Induced Epithelial to Mesenchymal Transition by Deactivating GSK3�/Snail Signaling Pathway in Renal Tubular Epithelial Cells
- (2014) Aiping Lan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells
- (2014) Horacio Cardenas et al. Epigenetics
- Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
- (2014) Ana Slipicevic et al. GYNECOLOGIC ONCOLOGY
- Perineal Powder Use and Risk of Ovarian Cancer
- (2014) S. C. Houghton et al. JNCI-Journal of the National Cancer Institute
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
- (2014) W. Wen et al. MOLECULAR CANCER THERAPEUTICS
- Serum microRNAs in clear cell carcinoma of the ovary
- (2014) Angel Chao et al. Taiwanese Journal of Obstetrics & Gynecology
- A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
- (2014) Ming Chen et al. OncoTargets and Therapy
- Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
- (2014) Stephan Lindsey et al. Frontiers in Oncology
- Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression
- (2013) Benjamin Koopmansch et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating IGF system and treatment outcome in epithelial ovarian cancer
- (2013) Yu-Fang Huang et al. ENDOCRINE-RELATED CANCER
- The Involvement of RhoA and Wnt-5a in the Tumorigenesis and Progression of Ovarian Epithelial Carcinoma
- (2013) Shuo Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Survival in Women With Grade 1 Serous Ovarian Carcinoma
- (2013) Amanda Nickles Fader et al. OBSTETRICS AND GYNECOLOGY
- Akt inhibitors: mechanism of action and implications for anticancer therapeutics
- (2013) Jaikrit Bhutani et al. Infectious Agents and Cancer
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration
- (2012) Nicolas Galazis et al. FERTILITY AND STERILITY
- ZEB/miR-200 feedback loop: At the crossroads of signal transduction in cancer
- (2012) Louise Hill et al. INTERNATIONAL JOURNAL OF CANCER
- Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis
- (2012) Julie M. Hall et al. MOLECULAR CARCINOGENESIS
- MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells
- (2012) Zheng Wu et al. TUMOR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started